Explain whythe activity is anti-competitive OR, if the court found otherwise, why not?

In the present case ofFederal Trade Commission et al. v. Vyera Pharmaceuticals, LLC et al.[2020], the defendants' anti-competitive activity was the decision to implement a comprehensive scheme that blocked customers' acquisition of lower-cost generic drug competition to their drug (Daraprim). The FTC and seven other states argued that such conduct violated Section 5 of the Federal Trade Commission Act, especially prohibiting anti-competitive practices.